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Henoch-Scho¨nlein purpura (HSP) is the most common systemic vasculitis in children, and renal involvement (HSP nephritis,
HSPN) is a severe manifestation. HSPN is histologically classified by the International Study of Kidney Disease in Children
(ISKDC) based on mesangial hypercellularity and the extent of glomerular crescents. Macrophages, categorized as M1 or M2,
frequently infiltrate in various glomerular and tubulointerstitial diseases and infiltration of specific subtypes is associated with
disease progression.Therefore, to identify whether infiltration ofM1 orM2macrophages has clinical significance, we quantified the
subtypes of macrophages in 49 HSPN specimens and correlated the counts with histologic features and clinical parameters. Higher
tubulointerstitial M2 counts were associated with chronic renal failure (CRF), ISKDC classes III-IV, and crescents (P<0.001, 0.002,
0.001). Glomerular M2 counts were significantly related to ISKDC classes III-IV and crescents (area under curve, AUC 0.804,
0.833). Tubulointerstitial M2 counts were associated with CRF, ISKDC classes III-IV, and crescents (AUC 0.872, 0.778, 0.830).
Tubulointerstitial M2 counts also revealed higher AUC than tubulointerstitial M1 counts for CRF (P=0.036) and ISKDC classes
III-IV (P=0.047). Glomerular M2 counts revealed higher AUC than glomerular M1 counts for ISKDC classes III–IV (P=0.024).
Tubulointerstitial M2 counts were the most powerful parameter for CRF (AUC 0.872) and revealed even higher AUC than ISKDC
classification (AUC0.716) with borderline significance (P=0.086) for CRF. In summary, tubulointerstitialM2 counts were a superior
parameter to tubulointerstitial M1 counts and even to ISKDC classification indicating the presence of CRF.
1. Introduction
Henoch-Scho¨nlein purpura (HSP) is the most common
systemic vasculitis in children. The histologic feature of
HSP is leukocytoclastic vasculitis of small vessels, and renal
involvement (HSP nephritis, HSPN) is a significant prognos-
tic indicator [1, 2]. The histology and pathogenesis of HSPN
are similar to IgA nephropathy and include IgA1-containing
immune complex deposits [3]. Although histologically simi-
lar, there are different classifications for IgA nephropathy and
HSPN. The Oxford classification is a histologic classification
of IgA nephropathy, which focuses not only on histologic
features, but also on their interobserver reliability and clinical
implications [4, 5]. It classifies cases according to the absence
or presence of four histologic parameters: mesangial hyper-
cellularity, endocapillary proliferation, segmental sclerosis or
adhesion, and tubular atrophy and interstitial fibrosis. For
HSPN, the International Study of Kidney Disease in Children
(ISKDC) is currently the most widely used classification sys-
tem. Mesangial hypercellularity and the extent of glomerular
crescents are parameters of ISKDC; however, the latter was
not considered in the original Oxford classification of IgA
nephropathy [4, 5] and has only very recently been included
in the revised version [6].
Macrophage infiltration is frequently observed in glom-
erular and tubulointerstitial diseases. There are several
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reports that the degree of macrophage infiltration, especially
infiltration of specific subtype, is related to the severity of
glomerular injury [7] and the progression of tubulointerstitial
fibrosis [8]. Activated macrophages are subdivided according
to their differentiation as M1 (classically activated) or M2
(alternatively activated) macrophages. M1 macrophages are
activated by interferon-𝛾 and exert proinflammatory proper-
ties, whereas M2 macrophages are activated by interleukin-
4 and interleukin-10 and exert anti-inflammatory, immuno-
suppressive, and extracellular matrix remodeling activities
[9]. Glomerular injury and tubular injury cause chemoattrac-
tion of macrophages and subsequent inflammatory reactions
and tissue remodeling through the production of cytokines,
such as transforming growth factor-𝛽. A few studies have
investigated the significance of macrophage subtype in IgA
nephropathy. Ikezumi et al. reported that M2 macrophages
were observed in glomeruli and interstitium of early-onset
IgA nephropathy, and these cells were correlated with
glomerular matrix expansion [10]. Kawasaki et al. observed
that severe IgA nephropathy cases, which are resistant to
treatment, revealed more frequent M1 macrophage infiltra-
tion [11]. In contrast, Li et al. reported that CD163-positive
M2macrophageswere responsible for crescent formation and
acute tubular injury in IgA nephropathy [12].
It has been recently reported that the endocapillary prolif-
eration and tubular atrophy/interstitial fibrosis aspects of the
Oxford classification, together with the crescent formation
of the ISKDC classification, are significantly related to the
renal survival of HSPN patients [13]. These three features are
known to be associated with macrophage infiltration [12, 14–
16]. Therefore, we evaluated the macrophage subclasses in
renal biopsy specimens of HSPN patients.The quantity of M1
and M2 macrophages were analyzed in relation to histologic
features and clinical parameters.
2. Materials and Methods
We retrieved 49 cases of biopsy-proven HSPN from the renal
biopsy registry and electronic medical records of Severance
Hospital, Seoul, Korea. Clinical history and laboratory data
were collected by reviewing electronic records. Glomerular
filtration rate (GFR) was estimated using the Modification
of Diet in Renal Disease study equation [17]. Chronic
renal failure (CRF) was defined as a GFR of less than 60
ml/minute/1.73 m2 for more than 3 months, which corre-
sponds to chronic kidney disease stage 3-5 according to the
National Kidney Foundations Practice Guidelines [18]. Ele-
vation of creatinine (ECr) was defined as elevated serum cre-
atinine greater than or equal to 1.0mg/dl at the time of biopsy.
Paraffin-embedded renal tissues were cut into 3 𝜇m
sections and were stained using the Bond-III automated
staining platform (Leica Microsystems, Ltd., Wetzlar, Ger-
many). Antibodies used were anti-human MRP 8/14 (Cal-
protectin) monoclonal antibody (dilution 1:200; clone 27E10;
BMA Biomedicals, Augst, Switzerland) and anti-human
CD163 monoclonal antibody (dilution 1:150; clone 10D6;
Leica Biosystems, Wetzlar, Germany). After deparaffiniza-
tion and rehydration by graded alcohol and water, heat-
induced antigen retrieval was performed in the Bond Epitope
Retrieval Solution 1/2 (Leica Microsystems, Ltd.) at 98∘C for
20 minutes.
The number of immunoreactive cells was counted in
glomeruli and tubulointerstitium, separately. The average
number of positive cells per glomerulus was counted in all
glomeruli. Glomeruli showing global sclerosis or crescent
formation were excluded from the count. Tubulointerstitial
macrophage infiltration was expressed as the average number
of positive cells per high power field (HPF, 400x) after
counting 10 consecutive HPFs. The number of M1 (MRP
8/14-positive) and M2 macrophages (CD163-positive) was
analyzed in relation to histologic and clinical features, such
as crescent formation, serum creatinine level, hematuria, and
proteinuria. This study was approved by the Institutional
Review Board of Gangnam Severance Hospital (3-2015-
0067). The Institutional Review Board exempted the authors
fromobtaining informed consent because of the retrospective
nature of this study.
3. Statistical Analysis
Statistical comparisons were conducted using an indepen-
dent Student’s t-test for continuous variables and chi-square
or Fisher’s exact test for categorical variables. The statistical
analyses were performed with SPSS version 23.0 (IBM,
Armonk, NY, USA). Area under curve (AUC) was com-
pared from receiver operating characteristic curves with
95% confidence intervals (95% CI), and AUC comparisons
were performed withMedCalc version 18 (MedCalc Software
bvba, Ostend, Belgium) using the DeLong method [19].
Statistical significancewas given to resultswithP-values<0.05
or AUC>0.7, and borderline significance was given to P-
values between 0.05 and 0.10.
4. Results
The baseline characteristics of 49 HSPN patients, including
clinical presentation and laboratory findings, are shown
in Table 1. Infiltration of M1 and M2 macrophages was
observed in glomeruli and tubulointerstitium (Figures 1(a)
and 1(b)). The mean glomerular M1 and M2 counts (± stan-
dard deviation, SD) were 1.0±2.8 and 5.7±11.4, respectively,
and the mean tubulointerstitial M1 and M2 counts were
0.6±1.8 and 52.6±38.5, respectively. The differences in clini-
cal, laboratory, light microscopic, and immunofluorescence
findings between groups with and without ECr at the time
of biopsy, CRF at the time of biopsy, and ISKDC classes
are described in Tables 1 and 2. ECr cases were associated
with older age (P<0.001), higher body mass index (kg/m2,
P=0.003), lower GFR (P<0.001), and reduced serum albumin
(P=0.003) (Table 1). CRF cases were associated with older age
(P<0.001), higher serum creatinine (P=0.008), and reduced
serum albumin (P=0.006) (Table 1). ISKDC class III-IV cases
were associated with older age (P=0.047) and hypoalbumine-
mia (P=0.049) (Table 1). ECr cases were associated with
increased presence (P=0.047) and glomerular involvement
of crescents (P=0.036) (Table 2). CRF cases were associated
with presence of crescents (P=0.008), increased glomerular
crescent involvement (P=0.037), and IgM deposits (P=0.024)
(Table 2). ISKDC class III-IV cases were associated with
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Table 2: Light microscopy and immunofluorescence findings for patient groups based on GFR and ISKDC classification.
Factors
Renal failure Chronic renal failure ISKDC classiﬁcation
ECr
(n=17)
Non-ECr
(n=32) Pa
CRF
(n=13)
Non-CRF
(n=36) Pa
Class I-II
(n=25)
Class
III–IV
(n=24) P
a
Mean±SD
or n (%)
Mean±SD
or n (%)
Mean±SD
or n (%)
Mean±SD
or n (%)
Mean±SD
or n (%)
Mean±SD
or n (%)
Light microscopy studies
Number of glomeruli evaluated 13.8±6.6 19.5±9.6 0.037 13.1±6.7 19.1±9.3 0.046 17.0±8.1 18.1±10.0 0.696
% Glomeruli involved by crescent 13.6±14.6 4.7±8.1 0.036 13.6±13.5 5.7±10.0 0.037 0.0±0.0 15.8±11.8 <0.001
Presence of sclerotic glomeruli
[crescent] 10 (62.5) 10 (32.3) 0.047 9 (75.0) 11 (31.4) 0.008 0 (0.0) 20 (87.0) <0.001
Presence of endocapillary
proliferation 2 (11.8) 2 (6.3) 0.602 1 (7.7) 3 (8.3) 0.999 2 (8.0) 2 (8.3) 0.999
Immunoﬂuorescence studies
IgG 0.4±0.7 0.3±0.5 0.564 0.5±0.7 0.3±0.5 0.358 0.4±0.5 0.3±0.6 0.590
IgA 1.8±0.9 1.6±0.8 0.340 1.6±0.9 1.7±0.8 0.614 1.8±0.8 1.5±0.8 0.259
IgM 0.3±0.3 0.2±0.2 0.120 0.3±0.3 0.2±0.2 0.024 0.2±0.2 0.3±0.3 0.245
C3 0.7±0.7 0.5±0.4 0.358 0.7±0.7 0.6±0.5 0.626 0.6±0.4 0.6±0.6 0.671
C4 0.0±0.0 0.0±0.1 0.083 0.0±0.1 0.0±0.1 0.788 0.0±0.1 0.0±0.1 0.585
C1q 0.0±0.0 0.0±0.1 0.161 0.0±0.0 0.0±0.1 0.396 0.0±0.1 0.0±0.0 0.161
Fibrinogen 1.4±1.0 1.1±0.8 0.211 1.3±0.8 1.2±0.8 0.718 1.1±0.8 1.3±0.9 0.424
aChi-square test, Mantel-Haenszel Chi-square test, or Fischer exact test for categorical variables; P-value < 0.05 was considered statistically significant.
GFR, glomerular filtration rate; ISKDC, International Study of Kidney Disease in Children.
(a) (b)
Figure 1: Figure 1: Representative microscopic images of MRP 8/14-positive M1 (a) and CD163-positive M2macrophage (b) in glomeruli and
tubulointerstitium (x400).
increased glomerular crescent involvement (P<0.001) and
presence of crescents (P<0.001) (Table 2).
The quantities of M1 and M2 macrophages were com-
pared according to the presence of ECr, CRF, ISKDC classes
III-IV, or presence of crescents. Both glomerular and tubu-
lointerstitial M1 counts tended to be higher in cases with
ECr (P=0.088, 0.055) (Table 3). Tubulointerstitial M2 counts
were higher in cases with ECr (P=0.001), CRF (P<0.001),
ISKDC classes III-IV (P=0.002), and presence of crescents
(P=0.001) (Table 3).There was no difference in the number of
M1 and M2 macrophages in glomeruli or tubulointerstitium
according to the presence of endocapillary proliferation (data
not shown).
The AUC was obtained to evaluate the correlation to
ECr, CRF, ISKDC classes III-IV, and presence of crescents.
Glomerular M1 counts were significantly associated with
ECr (AUC 0.724) in contrast to glomerular M2 counts,
which were not associated with ECr (AUC 0.617) (Table 4).
Glomerular M2 counts were significantly associated with
ISKDC classes III-IV (AUC 0.804) and presence of crescents
(AUC 0.833) (Table 4). M1 counts in tubulointerstitium and
likewise M1 counts in glomeruli were associated with ECr
(AUC 0.769) but not associated with CRF, ISKDC classes III-
IV, or presence of crescents (Table 4). Tubulointerstitial M2
counts were associated with ECr (AUC 0.818), CRF (AUC
0.872), ISKDC classes III-IV (AUC 0.778), and presence of
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Table 4: Area under curve (AUC) comparison of receiver operator characteristic (ROC) curves for the association with renal failure or
ISKDC classification.
Factors ECr
a CRFb ISKDC III-IV Crescents
AUC 95% C.I. AUC 95% C.I. AUC 95% C.I. AUC 95% C.I.
Glomerular M1 count 0.724 0.578 to 0.842 0.656 0.507 to 0.786 0.611 0.461 to 0.747 0.637 0.484 to 0.772
Glomerular M2 count 0.617 0.467 to 0.752 0.610 0.460 to 0.746 0.804 0.666 to 0.904 0.833 0.696 to 0.926
Tubulointerstitial M1 count 0.769 0.627 to 0.878 0.700 0.552 to 0.822 0.602 0.452 to 0.739 0.696 0.545 to 0.822
Tubulointerstitial M2 count 0.818 0.682 to 0.914 0.872 0.745 to 0.950 0.778 0.637 to 0.884 0.830 0.692 to 0.923
ISKDC classification 0.711 0.562 to 0.833 0.716 0.568 to 0.837
aDefinition of elevation of creatinine (ECr) is the status of high creatinine ≥1.0 mg/dl.
bDefinition of chronic renal failure (CRF) is the status of low GFR, which is below 60 ml/min/1.73 m2 for more than 3 months.
ISKDC, International Study of Kidney Disease in Children.
crescents (AUC 0.830) (Table 4). ISKDC classification was
significantly associated with ECr (AUC 0.711) and CRF (AUC
0.716) (Table 4).
M1 counts in glomeruli, as well as M1 and M2 counts in
tubulointerstitium, revealed higher AUC than ISKDC classi-
fication for the association with ECr but without statistical
significance (P=0.693, 0.399, 0.212). Additionally, the AUC
difference between tubulointerstitialM1 (AUC0.769) andM2
counts (AUC 0.818) was not statistically significant (P=0.618).
Conversely, tubulointerstitial M2 counts revealed higher
AUC than tubulointerstitial M1 counts for the association
with CRF (P=0.036) and ISKDC classes III-IV (P=0.047)
(Table 4 and Figures 2(a) and 3(a)). Glomerular M2 counts
revealed higher AUC than glomerular M1 counts for the
association with ISKDC classes III-IV (P=0.024) (Table 4
and Figure 3(b)). Tubulointerstitial M2 counts were the
most powerfully associated factor with CRF (AUC 0.872)
and revealed even higher AUC than ISKDC classification
with borderline significance (P=0.086) for CRF (Table 4 and
Figure 2(b)).
5. Discussion
Glomerular and tubulointerstitial macrophage infiltration
plays a significant role in the progression of various renal dis-
eases. Renal glomerular and tubulointerstitial fibrosis, a cru-
cial final common pathway that dictates renal function and
survival, is tightly spatiotemporally related to macrophage
infiltration [20]. Macrophages produce supporting factors
for myofibroblasts, such as galectin-3, transforming growth
factor-𝛽, insulin-like growth factor 1, and platelet-derived
growth factor, and also play a role in the deposition and
organization of the extracellular matrix by modulating the
balance of metalloproteinases and tissue inhibitors of met-
alloproteinases [20, 21]. Moreover, degradative metallopro-
teinases released by macrophages can damage the tubular
basement membrane leading to epithelial-to-mesenchymal
transition [21]. Just as epithelial-to-mesenchymal transition is
an important origin of bone-marrow-derivedmyofibroblasts,
the macrophage itself is also an important origin of myofi-
broblasts through the macrophage-myofibroblast transition
[20, 22–24].
There have been several studies showing that the dom-
inance of M1 or M2 macrophages leads to progression of
kidney diseases. M1 polarization has been suggested to be
pathogenic in antiglomerular basement membrane glomeru-
lonephritis (demonstrated by interferon-𝛾-augmented adop-
tive transfer) [25, 26], early stage ischemia-reperfusion injury
(reflecting damage after renal allograft) [27], and Adri-
amycin nephropathy (demonstrated by adoptive transfer of
CpG DNA-activated M1 macrophages) [28]. In contrast, M2
macrophages have been suggested to be pathogenic in the
later stage of ischemia-reperfusion injury [27]. Studies have
demonstrated M1 polarization is associated with diabetic
nephropathy in streptozotocin-induced type I diabeticmouse
and rat models [26, 29, 30]. However, another study revealed
M2 polarization is associated with diabetic nephropathy in
rats with hyperalbuminuric streptozotocin-induced type I
diabetes [26, 31]. Some studies demonstratedM2 polarization
is associated with exacerbation of lupus nephritis [32, 33],
whereas another study showed M1 macrophages are associ-
ated with the onset of lupus nephritis [34].
There are a few studies showing that M1 and M2
macrophages take part in IgA nephropathy and HSPN [10–
12].More specifically,M2macrophages are related to crescent
formation in IgAnephropathy andHSPN [7, 12]. In this study,
we analyzed the significance of M1 and M2 macrophages in
HSPN in association with clinical parameters. M1 and M2
macrophages were counted in glomeruli and tubulointersti-
tium, separately. Of note, glomerular infiltration was counted
only in nonsclerotic glomeruli without crescents, because it is
already known that the number of M2macrophages is signif-
icantly correlated with crescents [12] and glomerulosclerosis
[35].
Our analysis demonstrated that the quantity of glomeru-
lar M2 macrophages showed significant association with
the development of crescents and higher ISKDC classes,
of which the main discriminating factor is the number
of crescents. Therefore, high numbers of glomerular M2
macrophages correlated with the development of crescents,
which is consistent with previous studies [12]. In contrast,
glomerular M1 macrophage counts were higher in the ECr
group than the non-ECr group with borderline significance,
whereas the association with ECr by AUC was significant.
This correlation might be partially explained by the fact that
M1 macrophages have proinflammatory properties, and M2
macrophages have profibrotic properties [36, 37].
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Figure 2: Area under curve (AUC) comparison of receiver operating characteristic (ROC) curves of tubulointerstitial M1 and M2
macrophages counts (a) and tubulointerstitial M2 counts and ISKDC classiﬁcation (b) for the association with chronic renal failure.
(a) AUC of tubulointerstitial M2 counts [0.872 (95% CI 0.745 to 0.950)] was wider than tubulointerstitial M1 counts [0.700 (95% CI 0.552 to
0.822)] (P=0.036). (b) AUC of tubulointerstitial M2 counts [0.866 (95% CI 0.736 to 0.947)] was wider than AUC of ISKDC [0.716 (95% CI
0.568 to 0.837)] (P=0.086). The AUC 95%, CI, and P-values in AUC comparison were obtained from DeLong method. ISKDC, International
Study of Kidney Disease in Children.
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Figure 3: Area under curve (AUC) comparison of receiver operating characteristic (ROC) curves of tubulointerstitial M1 and M2
macrophage counts (a) and glomerular M1 and M2 macrophage counts (b) for the association with ISKDC classes III-IV. (a) AUC
of tubulointerstitial M2 counts [0.778 (95% CI 0.637 to 0.884)] was wider than AUC of tubulointerstitial M1 counts [0.602 (95% CI 0.452
to 0.739)] (P=0.047). (b) AUC of glomerular M2 counts [0.804 (95% CI 0.666 to 0.904)] was wider than AUC of glomerular M1 counts
[0.611 (95% CI 0.461 to 0.747)] (P=0.024).The AUC, 95% CI, and P-values in AUC comparison were obtained fromDeLong method. ISKDC,
International Study of Kidney Disease in Children; CI, confidence interval.
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Interestingly, we found that the quantity of tubuloint-
erstitial M2 macrophages was more prominently associated
with the development of ECr, CRF, crescent formation,
and higher ISKDC classes in both absolute counts and
AUC. Increased glomerular injury could have contributed
to more significant tubulointerstitial inflammation. Alterna-
tively, elevated tubulointerstitial inflammation and fibrosis
could have affected the progression of glomerular injury [38].
As HSPN is primarily a disease of the glomeruli, the former
is more plausible. However, it has been recently reported
that preexisting tubulointerstitial injury is a deteriorating
factor for the development and progression of glomerular
injury [39]. Therefore, there is a possibility that tubuloint-
erstitial M2 macrophages induced more severe glomerular
injury with crescent formation. Our observation that M2
macrophages had more significant clinical translation is
supported by previous studies. In an in vitro study, M2, but
not M1 macrophages promoted epithelial-to-mesenchymal
transition in cisplatin-induced nephrotoxicity, which was
characterized by apoptosis of tubular epithelial cells through
inflammatory mediators and oxidative stress [40]. In an
ischemia/reperfusion injury mouse model, M2, but not M1
macrophages revealed an important role in the progression of
fibrosis during acute kidney injury-to-chronic kidney disease
transition [41].
ISKDC classification considers only mesangial hypercel-
lularity and the extent of glomerular crescents, but other sig-
nificant components, such as vessels and tubulointerstitium,
are omitted [3, 42, 43]. Additionally, ISKDC classification
has been challenged by contradictory clinical outcomes in
several reports [44–47]. A new semiquantitative classifica-
tion, including activity index and chronicity index, has been
suggested recently on the grounds of improved sensitivity
for clinical outcomes [48]. We identified the superiority
of tubulointerstitial M2 macrophage counts to the current
ISKDC classification by AUC comparison analysis. As the
DeLong test is a conservative statistical method [49], the
borderline significance of the superiority of tubulointerstitial
M2 counts to ISKDC classification in terms of CRF shown
in this study may provide meaningful clinical implication. In
contrast to ISKDC classification, which concentrates only on
histologic features, tubulointerstitial M2 counts could guide
potential targeted therapy as it plays a key role in the dynamic
process of renal fibrogenesis [50, 51].
As HSPN is frequently diagnosed in pediatric patients in
very small biopsy specimens, this study has additional clinical
implications.When a biopsy ofHSPN is small andno crescent
is found, immunohistochemistry forM2macrophages would
be beneficial. Although this study does not provide a cut-off
value, elevated glomerular M2 counts may suggest unsam-
pled crescents, and higher tubulointerstitial M2 counts may
indicate a poor prognosis regarding acute and chronic renal
function deterioration.
There are several limitations in this study. First, the
outcomes, such as ECr and CRF, are based on initial clinical
data at the time of biopsy. Second, survival analysis could not
be performed due to lack of follow-up clinical data. Third,
possible confounding factors, such as age, body mass index,
and treatment modality, could not be adjusted due to the
retrospective nature of this study.
In conclusion, tubulointerstitial M2 counts were superior
to tubulointerstitial M1 counts and were even superior to
ISKDC classification in association with CRF of HSPN
patients. Tubulointerstitial M2 counts would not only aid to
predict outcomes and guide clinical practice, especially when
only a small biopsy sample is available, but may also provide
insight for potential therapeutic targets to prevent fibrosis
and renal failure. Future studies employing larger cohorts are
necessary to establish a grading system for tubulointerstitial
M2 counts.
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